Skip to Content
Search Menu

JAK-STAT-reitti sairauksien keskiössä

Väitöstutkimuksessa raportoitiin uusi JAK-STAT-reittiin vaikuttava potilasmutaatio sekä tutkittiin JAK-estäjien ominaisuuksia.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

New Safety Checklist for Antirheumatic Drugs

/ Lykke Skaarup / Tue Kragstrup
JAK-inhibitorsPsoriatic arthritisRheumatoid arthritisSpA
Roy Fleischmann

Differences and Similarities of the Four Approved JAK Inhibitors

/ Roy Fleischmann
JAK-inhibitors Play the Video 07:16

Managing Risks with Newer Oral Small Molecules in Patients with IBD

/ Parakkal Deepak
IBDJAK-inhibitors Play the Video 10:38

Treatment after JAK Inhibitor in Patients with Rheumatoid Arthritis – What to do Next?

/ Jan Andreasen
JAK-inhibitorsRheumatoid arthritis
Roy Fleischmann

Safety of JAK-inhibitors – do we need to be concerned?

/ Roy Fleischmann
EULAR22JAK-inhibitors Play the Video 12:49

JAK-inhibiittorit nivelreumassa

/ Anniina Virtanen / Olli Silvennoinen / Pia Isomäki
Biological treatmentJAK-inhibitorsRheumatoid arthritis
Back to top